Clinical trial
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
NCT04658303 is registered in ClinicalTrials.gov with Yana Najjar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
- Lead sponsor
- Yana Najjar
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 24, 2021
- Completion date
- August 31, 2029
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.